Gain's lead program in Parkinson's disease has been awarded funding support from The Michael J. Fox Foundation for ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

February is American Heart Month, which is an appropriate time to learn how genetic testing can protect your family.

Louisville is a shining example of how to connect disability, civil rights and equity. Combined activism can establish DEI ...

Quince Therapeutics, Inc. , a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, announced that it will host an investor ...

Learn more about whether Biogen Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

In “Seven Deadly Sins,” neurologist Guy Leschziner explores the science behind Dante’s greatest transgressions.

Conductor Daniel Barenboim says he has been diagnosed with Parkinson's disease. The 82-year-old issued a statement Thursday ...

Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.